Dapsone: modes of action, toxicity and possible strategies for increasing patient tolerance
- 1 November 1993
- journal article
- review article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 129 (5), 507-513
- https://doi.org/10.1111/j.1365-2133.1993.tb00476.x
Abstract
Dapsone is useful in the treatment of a number of inflammatory conditions which are characterized by neutrophil infiltration. It is the drug of choice for suppression of the symptoms of dermatitis herpetiformis, as it inhibits the process by which neutrophils leave the circulation and migrate to lesional sites. It also prevents the tissue destruction normally caused by the neutrophils' respiratory burst. Although dapsone can cause a number of serious idiosyncratic reactions, such as agranulocytosis, tolerance of the drug at higher doses is more usually determined by its haematological side-effects of methaemoglobinaemia and haemolysis. These effects are due entirely to the hepatic N-hydroxylation of dapsone to a hydroxylamine metabolite, some of which escapes from the liver and rapidly enters red cells. Attempts have been made to counteract the haemotoxic effects of the metabolite by the use of antioxidants such as vitamins E and C. Recently, the co-administration of a metabolic inhibitor such as cimetidine has been shown to reduce significantly dapsone-dependent methaemoglobinaemia, without any change in drug efficacy. It remains to be seen if this approach will be adopted clinically, to improve patient tolerance of high dapsone dosage.Keywords
This publication has 54 references indexed in Scilit:
- Mechanisms by which clofazimine and dapsone inhibit the myeloperoxidase system: A possible correlation with their anti-inflammatory propertiesBiochemical Pharmacology, 1991
- Mechanism of inhibition of myeloperoxidase by anti-inflammatory drugsBiochemical Pharmacology, 1991
- The effect of dapsone in steroid-dependent asthmaJournal of Allergy and Clinical Immunology, 1991
- Dapsone, Trimethoprim, and Sulfamethoxazole Plasma Levels during Treatment of Pneumocystis Pneumonia in Patients with the Acquired Immunodeficiency Syndrome (AIDS)Annals of Internal Medicine, 1989
- Tissue Destruction by NeutrophilsNew England Journal of Medicine, 1989
- Compound I of myeloperoxidaseBiochemical and Biophysical Research Communications, 1980
- Sulfones and sulfonamides in dermatology todayJournal of the American Academy of Dermatology, 1979
- Bullous pemphigoid responding to sulfapyridine and the sulfonesArchives of Dermatology, 1977
- Relapsing polychondritis treated with dapsoneArchives of Dermatology, 1976
- Malaria reference laboratory.BMJ, 1973